Companies’ News

Golden Seeds companies in the news

Ray Hoffman, producer and host of CEO Radio on WCBS Newsradio 880, interviews CEO, LouWasilewski of Acivilate. Listen Here. 02/4

Lark recently partnered up with 23andMe to add genetic data to Lark’s Wellness and Diabetes Prevention Programs. Read More Here. 01/08

Oculogica Receives FDA marketing authorization for EyeBOX, the First Non-Invasive, Baseline-Free Test for Concussion  Read More Here. 01/3

Adoption Momentum For Paradigm4’s UK Biobank Platform 12/11

Devcon raises $4.5M to beef up adtech security

Cadenza Innovation’s Christina Lampe-Onnerud Joins Smart Cities & Energy Panel at Xconomy’s X-CON 2018 Conference Reada More Here. 10/29

Cognition Therapeutics to Sponsor Third International Symposium on Sigma-2 Receptors: Role in Health and Disease during the Society for Neuroscience Annual Meeting. Read More Here.10/24

Golden Seeds companies Cadenza Innovations, nVision and TomboyX included in Inc’s top 100 Female Founders. Read More Here. 10/4

Brandwatch & Crimson Hexagon Merger. Read More Here.10/4

Cognition Therapeutics Receives $16.6 Million Multiyear NIA Grant for Phase 2 SHINE Study of Elayta™ in Patients with Mild-to-Moderate Alzheimer’s Disease. Read More Here. 10/2

DEVCON Selected to Demonstrate Leading Anti-Ad Fraud Technology at Venture Atlanta 2018. Read More Here. 9/25

BAK Partners with Lithium-ion Battery Technology Company Cadenza Innovation to Introduce Startup’s “Supercell” Platform to China. Read More Here. 9/16

Cadenza Innovation Named as Technology Pioneer by World Economic Forum. Learn More 06/21

Forbes shares Millennials Love Lovesac, But Will Shareholders? The Furniture Company Announces $42M IPO. Learn More 06/19

Cognition Therapeutics Initiates NIA-Funded SPARC Study of Elayta™ to Assess Changes in Synaptic Density and Cognitive Performance in Alzheimer’s Disease. Learn more 06/18

RenovoRX completes $10 million financing for Innovative Treatment for Advance Pancreatic Cancer.   Learn More 05/23

Groupize makes The Skift 2018 Corporate Travel Innovators List 5/2

Dev/Con Detect helps get the first ever conviction for theft and money laundering via ad frau. Link to Press release 4/25

MIT Technology Review speaks with Oculogica regarding their groundbreaking Eye-Tracking technology to diagnose concussion 4/25

Congratulations to the outstanding Golden Seeds company Oculogica – and its breakthrough technology for diagnosing concussions – for winning the coveted Luis Villalobos Award for innovation at the Angel Capital Association Summit 4/19

Crimson Hexagon’s Founder and Chair of the Board, Dr. Gary King, Spearheads Groundbreaking Industry-Academic Research Partnership with Facebook.  Link to Press release  4/11

Cognition Therapeutics presenting evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined Advances in Alzheimer Therapy and the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders Meeting. Link to Press release 3/14

CEO of Crimson Hexagon, Stephanie Newby,  shares with Forbes the Fear Factors for Women Entrepreneurs 2/28

Zenflow completes Series A round to perform additional clinical studies that will serve to further validate safety and effectiveness of their medical device and to prepare for commercialization 2/18

Tania Yuki, founder and CEO of Shareablee, is featured in CMSWire to discuss her journey and female entrepreneurship 12/17

Congrats to JoyLux raising a funding round and being featured by GeekWire. The company is preparing to launch its medical device product in the U.S.  12/17

Groupize Rolls Out New Automated Hotel-Booking Feature 11/17

Oculogica gets featured in Inno to show how the company is working to change the way brain injuries are diagnosed and defined 11/17

Healthcare Analytics News features Lark’s Weight Loss Health Coach AI to explain how AI can help patients with diabetes lose weight 11/17

Day Zero Diagnostics reduces infectious disease identification time to ensure the correct antibiotic course. PSFK highlights the company’s efforts to tackle the problem of antibiotic resistance 10/17

Cognition Therapeutics receives Fast Track designation from the FDA for their investigational drug for the treatment of patients with Alzheimer’s disease. Link to press release 10/17